Diagnosis dan Tata Laksana Mild Cognitive Impairment (MCI)

Celine Anindytha Pranata

doi:10.56951/txsmb181

Diagnosis dan Tata Laksana Mild Cognitive Impairment (MCI)

Penulis

Celine Anindytha Pranata Rumah Sakit Umum Hermina Depok

DOI:

https://doi.org/10.56951/txsmb181

Kata Kunci:

gangguan kognitif ringan, mild cognitive impairment, MCI, gangguan kognitif, gangguan memori, predemensia

Abstrak

Saat ini di dunia terjadi peningkatan jumlah populasi lanjut usia. Pada tahun 2020 terdapat 1,4 miliar penduduk di dunia yang berusia ≥60 tahun dan diprediksi meningkat sebanyak dua kali lipat pada tahun 2050. Penurunan fungsi kognitif dan memori merupakan salah satu konsekuensi dari proses penuaan yang dapat memengaruhi kualitas hidup seseorang. Mild cognitive impairment (MCI) merupakan kondisi patologis dan merupakan stadium preklinik serta transisi antara proses penuaan normal dengan demensia. Deteksi dan intervensi dini kondisi MCI dapat memperlambat onset dan mencegah progresivitas MCI menjadi demensia. Penulisan artikel ini bertujuan untuk memberikan gambaran umum mengenai MCI yang meliputi faktor risiko, tanda-tanda klinis (subjektif dan objektif), perjalanan penyakit, penegakan diagnosis, serta rekomendasi tata laksana MCI berdasarkan studi dan pedoman yang ada.

Unduhan

Baca Selengkapnya

Referensi

Hebert LE, Weuve J, Scherr PA E DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Am Acad Neurol. 2013;80:1778783. doi:10.1002/jcu.1870130614. DOI: https://doi.org/10.1212/WNL.0b013e31828726f5

Jongsiriyanyong S, Limpawattana P. Mild cognitive impairment in clinical practice: a review article. Am J Alzheimers Dis Other Demen. 2018;33(8):500-7. doi:10.1177/1533317518791401. DOI: https://doi.org/10.1177/1533317518791401

Ayati Z, Yang G, Ayati MH, Emami SA, Chang D. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther. 2020;20(1):1-10. doi:10.1186/s12906-020-03102-3. DOI: https://doi.org/10.1186/s12906-020-03102-3

Mcgirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z. Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms. Neurology 2022;98(21):E2132-9. doi:10.1212/WNL.0000000000200256. DOI: https://doi.org/10.1212/WNL.0000000000200256

Ha I. Mild cognitive impairment (MCI): Pathogenesis and treatments. Clin Psychopharmacol Neurosci. 2009;7(1):3-8.

Casagrande M, Marselli G, Agostini F, Forte G, Favieri F, Guarino A. The complex burden of determining prevalence rates of mild cognitive impairment: a systematic review. Front Psychiatry 2022;13. doi:10.3389/fpsyt.2022.960648. DOI: https://doi.org/10.3389/fpsyt.2022.960648

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment report of the guideline development, dissemination, and implementation. Neurology 2018;90(3):126-35. doi:10.1212/WNL.0000000000004826. DOI: https://doi.org/10.1212/WNL.0000000000004826

Shah Y, Tangalos EG, Petersen R. Mild cognitive impairment. When is it a precursor to Alzheimer’s disease? Geriatr Switz. 2000;55:62-5.

NIH. What is mild cognitive impairment? National Institute of Aging. Available at https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/what-mild-cognitive-impairment#:~:text=Some%20older%20

adults%20have%20more,increases%20as%20someone%20gets%20older accessed November 15, 2023.

Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology 2012;79(15):1591-8. doi:10.1212/WNL.0b013e31826e26b7. DOI: https://doi.org/10.1212/WNL.0b013e31826e26b7

Kim M, Moon SY. Need for an update for the guideline for the management of mild cognitive impairment. Dement Neurocognitive Disord. 2022;21(4):107. doi:10.12779/dnd.2022.21.4.107. DOI: https://doi.org/10.12779/dnd.2022.21.4.107

Shruti A, Schoo C. Mild cognitive impairment. In: Stat Pearls (Internet). Treasure Island (FL): StatPearls Publishing; 2024. Available at https://www.ncbi.nlm.nih.gov/books/NBK599514/ accessed July 4, 2024.

Lu Y, Liu C, Yu D, Fawkes S, Ma J, Zhang M, et al. Prevalence of mild cognitive impairment in communitydwelling Chinese populations aged over 55 years: a meta-analysis and systematic review. BMC Geriatr. 2021;21(1):1-16. doi:10.1186/s12877-020-01948-3. DOI: https://doi.org/10.1186/s12877-020-01948-3

Hope K. Role of nurses in addressing modifiable risk factors for early Alzheimer’s disease and mild cognitive impairment. Br J Nurs. 2020;29(8):460-9. DOI: https://doi.org/10.12968/bjon.2020.29.8.460

Sanford AM. Mild cognitive impairment. Clin Geriatr Med. 2017;33(3):325-37. doi:10.1016/j.cger.2017.02.005. DOI: https://doi.org/10.1016/j.cger.2017.02.005

Katayama O, Lee S, Bae S, Makino K, Shinkai Y. Modifiable risk factor possession patterns of dementia in elderly with MCI: a 4-year repeated measures study. 2020:1-12. DOI: https://doi.org/10.1002/alz.040736

Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753-72. doi:10.1016/j.cger.2013.07.003. DOI: https://doi.org/10.1016/j.cger.2013.07.003

Chen P, Cai H, Bai W, Zhang Q, Su Z, Tang YL, et al. Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys. Transl Psychiatry. 2023;13(1):1-11. doi:10.1038/s41398-023-02361-1. DOI: https://doi.org/10.1038/s41398-023-02361-1

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270-9. doi:10.1016/j.jalz.2011.03.008. DOI: https://doi.org/10.1016/j.jalz.2011.03.008

Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol. 2021;268(5):1615-22. doi:10.1007/s00415-019-09506-7. DOI: https://doi.org/10.1007/s00415-019-09506-7

Anderson ND. State of the science on mild cognitive impairment (MCI). CNS Spectr. 2019;24(1):78-87. doi:10.1017/S1092852918001347. DOI: https://doi.org/10.1017/S1092852918001347

Small GW. Updates in the management of mild cognitive impairment and Alzheimer disease. J Fam Pract. 2022;71(6):S82-7. doi:10.12788/jfp.0374. DOI: https://doi.org/10.12788/jfp.0374

Chen YX, Liang N, Li XL, Yang SH, Wang YP, Shi NN. Diagnosis and treatment for mild cognitive impairment: a systematic review of clinical practice guidelines and consensus statements. Front Neurol. 2021;12:719849.

doi: 10.3389/fneur.2021.719849. DOI: https://doi.org/10.3389/fneur.2021.719849

Petersen R. Mild cognitive impairment. Continuum (Minneap Minn). 2016;22(2 Dementia):404-18. DOI: https://doi.org/10.1212/CON.0000000000000313

Assaf G, El Khoury J, Jawhar S, Rahme D. Mild cognitive impairment and modifiable risk factors among Lebanese older adults in primary care. Asian J Psychiatr. 2021;65:102828. doi:10.1016/j.ajp.2021.102828. DOI: https://doi.org/10.1016/j.ajp.2021.102828

Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet 2017;390(10113):2673-734. doi:10.1016/S0140-6736(17)31363-6. DOI: https://doi.org/10.1016/S0140-6736(17)31363-6

Fenech M. Vitamins associated with brain aging, mild cognitive impairment, and Alzheimer disease: biomarkers, epidemiological and experimental evidence, plausible mechanisms, and knowledge gaps. Adv Nutr. 2017;8(6):958-70. doi:10.3945/an.117.015610. DOI: https://doi.org/10.3945/an.117.015610

McCleery J, Abraham RP, Denton DA, Rutjes AWS, Chong LY, Al-Assaf AS, et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Cochrane Database Syst Rev. 2018;11(11):CD011905. doi:10.1002/14651858.CD011905.pub2. DOI: https://doi.org/10.1002/14651858.CD011905.pub2

Ravi SK, Ramesh BN, Kj S, Poyya J, Karanth J, Raju NG, et al. Neuroprotective role of herbal alternatives in circumventing Alzheimer’s disease through multi-targeting approach - a review. Egypt J Basic Appl Sci. 2022;9(1):91-124. doi:10.1080/2314808X.2021.2021749. DOI: https://doi.org/10.1080/2314808X.2021.2021749

Alzobaidi N, Quasimi H, Emad NA, Alhalmi A, Naqvi M. Bioactive compounds and traditional herbal medicine: promising approaches for the treatment of dementia. Degener Neurol Neuromuscul Dis. 2021;11:1-14. doi:10.2147/dnnd.s299589. DOI: https://doi.org/10.2147/DNND.S299589

Gregory J, Vengalasetti Y V., Bredesen DE, Rao R V. Neuroprotective herbs for the management of Alzheimer’s disease. Biomolecules. 2021;11(4):1-19. doi:10.3390/biom11040543. DOI: https://doi.org/10.3390/biom11040543

Huang X, Zhao X, Li B, Cai Y, Zhang S, Wan Q, et al. Comparative efficacy of various exercise interventions on cognitive function in patients with mild cognitive impairment or dementia: a systematic review and network meta-analysis. J Sport Heal Sci. 2022;11(2):212-23. doi:10.1016/j.jshs.2021.05.003. DOI: https://doi.org/10.1016/j.jshs.2021.05.003